Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a new vaccine supply agreement with the U.S. government to support the continued fight against COVID-19. Under the agreement, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg). This may include adult Omicron-adapted COVID-19 vaccines, subject to authorization from the U.S. Food and Drug Administration (FDA).
Pfizer and BioNTech announce new agreement with U.S. government to provide additional doses of COVID-19 vaccine
July 3, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022